- The report contains detailed information about Cardiovascular Systems Inc. that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
- Another part of the report is a SWOT-analysis carried out for Cardiovascular Systems Inc.. It involves specifying the objective of the company's business and identifies the different factors that are favorable and unfavorable to achieving that objective. SWOT-analysis helps to understand company’s strengths, weaknesses, opportunities, and possible threats against it.
- The Cardiovascular Systems Inc. financial analysis covers the income statement and ratio trend-charts with balance sheets and cash flows presented on an annual and quarterly basis. The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency. This sort of company's information will assist and strengthen your company’s decision-making processes.
- In the part that describes Cardiovascular Systems Inc. competitors and the industry in whole, the information about company's financial ratios is compared to those of its competitors and to the industry. The unique analysis of the market and company’s competitors along with detailed information about the internal and external factors affecting the relevant industry will help to manage your business environment. Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
- Also the report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of Cardiovascular Systems Inc. business.
About Cardiovascular Systems Inc.
Cardiovascular Systems, Inc., a medical device company, focuses on developing and commercializing treatment systems for vascular disease in the United States.
The companys primary products include the Diamondback 360 PAD System (Diamondback 360°) and the Diamondback Predator 360° (Predator 360°), are catheter-based platforms treating a range of plaque types in leg arteries both above and below the knee and addresses various limitations associated with existing treatment alternatives. It also intends to pursue approval of its products for coronary use. It refers the Diamondback 360° and the Predator 360° collectively as the Diamondback Systems. The two technologies used in the Diamondback Systems are plaque modification through differential sanding and plaque removal.
The Diamondback Systems can be used to treat plaque in multiple anatomic locations.
Below-the-Knee Peripheral Artery Disease: Arteries below the knee has small diameters and may be diffusely diseased, calcified or both, limiting the effectiveness of traditional devices. The Diamondback Systems are effective in both diffuse and calcified vessels. This was demonstrated in the OASIS trial, where lesions treated with the Diamondback 360° were behind or below the knee.
Above-the-Knee Peripheral Artery Disease: Plaque in arteries above the knee may also be diffuse, fibrotic, and calcific. Its products are being used to treat lesions above the knee.
Coronary Artery Disease: The company has developed a version of the Diamondback 360° to treat coronary arteries. It has conducted various bench studies, four pre-clinical animal studies, and its ORBIT I 50-patient human clinical study to evaluate the Diamondback 360° in coronary artery disease.
The company also offers multiple accessory devices designed to complement the use of the Diamondback Systems, and it has entered into distribution agreements with Medtronic, Inc. and Asahi-Intecc, Ltd. It markets the following products: ViperSlide Lubricant a lubricant designed to optimize the operation of the Diamondback Systems and ViperTrack Radiopaque Tape a radiopaque tape to assist in measuring lesion lengths and marking lesion locations.
The companys competitors include Abbott Laboratories; Boston Scientific; Cook; Johnson & Johnson; Medtronic; Covidien; Spectranetics; Boston Scientific; and Pathway Medical Technologies.
Cardiovascular Systems, Inc. was founded in 1989.
The above Company Fundamental Report is a half-ready report and contents are subject to change.
It means that we have all necessary data in our database to prepare the report but need 2-3 days to complete it. During this time we are also updating the report with respect to the current moment. So, you can get all the most recent data available for the same price. Please note that preparation of additional types of analyses requires extra time.
1. CARDIOVASCULAR SYSTEMS INC. COMPANY PROFILE
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History
2. CARDIOVASCULAR SYSTEMS INC. BUSINESS OVERVIEW
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units
3. CARDIOVASCULAR SYSTEMS INC. SWOT ANALYSIS
4. CARDIOVASCULAR SYSTEMS INC. FINANCIAL ANALYSIS
4.1.1. Income Statement
4.1.2. Balance Sheet
4.1.3. Cash Flow
4.2. Financial Ratios
4.2.2. Margin Analysis
4.2.3. Asset Turnover
4.2.4. Credit Ratios
4.2.5. Long-Term Solvency
4.2.6. Growth Over Prior Year
4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot
5. CARDIOVASCULAR SYSTEMS INC. COMPETITORS AND INDUSTRY ANALYSIS
5.1. Cardiovascular Systems Inc. Direct Competitors
5.2. Comparison of Cardiovascular Systems Inc. and Direct Competitors Financial Ratios
5.3. Comparison of Cardiovascular Systems Inc. and Direct Competitors Stock Charts
5.4. Cardiovascular Systems Inc. Industry Analysis
5.4.1. Healthcare Equipment/Supplies Industry Snapshot
5.4.2. Cardiovascular Systems Inc. Industry Position Analysis
6. CARDIOVASCULAR SYSTEMS INC. NEWS & EVENTS
6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events
7. CARDIOVASCULAR SYSTEMS INC. EXPERTS REVIEW1
7.1. Experts Opinion
7.2. Experts Estimates
8. CARDIOVASCULAR SYSTEMS INC. ENHANCED SWOT ANALYSIS2
9. UNITED STATES PESTEL ANALYSIS2
9.2. Economic Factors
9.3. Social Factors
9.4. Technological Factors
9.5. Environmental Factors
9.6. Legal Factors
10. CARDIOVASCULAR SYSTEMS INC. IFE, EFE, IE MATRICES2
10.2. External Factor Evaluation Matrix
10.3. Internal External Matrix
11. CARDIOVASCULAR SYSTEMS INC. PORTER FIVE FORCES ANALYSIS2
12. CARDIOVASCULAR SYSTEMS INC. VRIO ANALYSIS2
APPENDIX: RATIO DEFINITIONS
LIST OF TABLES
Cardiovascular Systems Inc. Key Facts
Income Statement Key Figures
Balance Sheet Key Figures
Cash Flow Statement Key Figures
Financial Performance Abbreviation Guide
Cardiovascular Systems Inc. Key Executives
Key Executives Biographies1
Key Executives Compensations1
Cardiovascular Systems Inc. Major Shareholders
Cardiovascular Systems Inc. History
Cardiovascular Systems Inc. Products
Revenues by Segment
Revenues by Region
Cardiovascular Systems Inc. Offices and Representations
Cardiovascular Systems Inc. SWOT Analysis
Yearly Income Statement Including Trends
Income Statement Latest 4 Quarters Including Trends
Yearly Balance Sheet Including Trends
Balance Sheet Latest 4 Quarters Including Trends
Yearly Cash Flow Including Trends
Cash Flow Latest 4 Quarters Including Trends
Cardiovascular Systems Inc. Profitability Ratios
Margin Analysis Ratios
Asset Turnover Ratios
Long-Term Solvency Ratios
Financial Ratios Growth Over Prior Year
Cardiovascular Systems Inc. Capital Market Snapshot
Cardiovascular Systems Inc. Direct Competitors Key Facts
Direct Competitors Profitability Ratios
Direct Competitors Margin Analysis Ratios
Direct Competitors Asset Turnover Ratios
Direct Competitors Credit Ratios
Direct Competitors Long-Term Solvency Ratios
Healthcare Equipment/Supplies Industry Statistics
Cardiovascular Systems Inc. Industry Position
Company vs. Industry Income Statement Analysis
Company vs. Industry Balance Sheet Analysis
Company vs. Industry Cash Flow Analysis
Company vs. Industry Ratios Comparison
Cardiovascular Systems Inc. Consensus Recommendations1
Analyst Recommendation Summary1
Price Target Summary1
Experts Recommendation Trends1
Revenue Estimates Analysis1
Earnings Estimates Analysis1
Revenue Estimates Trend1
Earnings Estimates Trend1
LIST OF FIGURES
Cardiovascular Systems Inc. Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Profit Margin Chart
Operating Margin Chart
Return on Equity (ROE) Chart
Return on Assets (ROA) Chart
Debt to Equity Chart
Current Ratio Chart
Cardiovascular Systems Inc. 1-year Stock Charts
Cardiovascular Systems Inc. 5-year Stock Charts
Cardiovascular Systems Inc. vs. Main Indexes 1-year Stock Chart
Cardiovascular Systems Inc. vs. Direct Competitors 1-year Stock Charts
Cardiovascular Systems Inc. Article Density Chart
2 – These sections are available only when you purchase a report with appropriate additional types of analyses.
The complete financial data is available for publicly traded companies.
Enhanced SWOT Analysis
- How to use the strengths to take advantage of the opportunities?
- How to use the strengths to reduce likelihood and impact of the threats?
- How to overcome the weaknesses that obstruct taking advantage of the opportunities?
- How to overcome the weaknesses that can make the threats a reality?
Key Factors Examined by PESTEL Analysis:
- Legal – What laws and legislation will exert influence on the style the business is carried out?
IFE, EFE, IE Matrices
Porter Five Forces Analysis
- What composes a threat of substitute products and services?
- Is there a threat of new competitors entering the market?
- What is the intensity of competitive rivalry?
- How big is the bargaining power of buyers?
- How significant is the bargaining power of suppliers?
- Tangible resources
- Intangible resources
- Innovation and Creativity
- Organizational capabilities
- Costly to imitate?
- Organized properly?